Spectranetics to Attend Upcoming Investor Conferences
November 07 2016 - 9:00AM
The Spectranetics Corporation (NASDAQ:SPNC), (“the Company”) today
announced that company management will be attending three upcoming
investor conferences.
On November 16th, 2016, the Company will attend the Stifel
Healthcare Conference at the Lotte New York Palace Hotel. The
fireside chat will begin at 8:45 am Eastern Standard Time and can
be accessed via the live webcast at
http://wsw.com/webcast/stifel5/spnc.
On November 17th, 2016, the Company will attend the Canaccord
Genuity Medical Technologies & Diagnostics Forum. The fireside
chat will begin at 10 am Eastern Standard Time and can be accessed
via the live webcast at
http://wsw.com/webcast/canaccord24/spnc.
Additionally, on November 30th, 2016, the Company will attend
the 28th Annual Piper Jaffray Healthcare Conference. Webcasting
details will be available two weeks prior to the event.
Access to each of the three webcasts will also be available in
the Events section of the Investor Relations website at
http://www.spectranetics.com/investor-relations/investor-events.
About Spectranetics
The Spectranetics Corporation develops, manufactures, markets
and distributes medical devices used in minimally invasive
procedures within the cardiovascular system. The Company's products
are available in over 65 countries and are used to treat arterial
blockages in the heart and legs and in the removal of pacemaker and
defibrillator leads.
The Company's Vascular Intervention (VI) products include a
range of laser catheters for ablation of blockages in arteries
above and below the knee, the AngioSculpt scoring balloon used in
both peripheral and coronary procedures, and the Stellarex
drug-coated balloon peripheral angioplasty platform, which received
European CE mark approval in December 2014. The Company also
markets support catheters to facilitate crossing of peripheral and
coronary arterial blockages, and retrograde access and guidewire
retrieval devices used in the treatment of peripheral arterial
blockages, including chronic total occlusions. The Company markets
aspiration and cardiac laser catheters to treat blockages in the
heart.
The Lead Management (LM) product line includes excimer laser
sheaths, dilator sheaths, mechanical sheaths and accessories for
the removal of pacemaker and defibrillator cardiac leads.
For more information, visit www.spectranetics.com.
Investor Relations Contacts
Zach Stassen
Sr. Director of Finance
zach.stassen@spnc.com
(719) 447-2292
Michaella Gallina
Director of Investor Relations
michaella.gallina@spnc.com
(719) 447-2417
The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart
From Mar 2024 to Apr 2024
The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart
From Apr 2023 to Apr 2024